6,7-Di-O-acetylsinococulineCAS# 1054312-81-0 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 1054312-81-0 | SDF | Download SDF |
PubChem ID | 9823255 | Appearance | Powder |
Formula | C22H27NO7 | M.Wt | 417.5 |
Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | [(1S,9S,12S,13S)-12-acetyloxy-3-hydroxy-4,11-dimethoxy-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5,10-tetraen-13-yl] acetate | ||
SMILES | CC(=O)OC1CC23CCNC(C2=C(C1OC(=O)C)OC)CC4=C3C(=C(C=C4)OC)O | ||
Standard InChIKey | XAQZCUNTDGRIEM-AKUOHEDMSA-N | ||
Standard InChI | InChI=1S/C22H27NO7/c1-11(24)29-16-10-22-7-8-23-14(18(22)21(28-4)20(16)30-12(2)25)9-13-5-6-15(27-3)19(26)17(13)22/h5-6,14,16,20,23,26H,7-10H2,1-4H3/t14-,16-,20-,22-/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
6,7-Di-O-acetylsinococuline Dilution Calculator
6,7-Di-O-acetylsinococuline Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.3952 mL | 11.976 mL | 23.9521 mL | 47.9042 mL | 59.8802 mL |
5 mM | 0.479 mL | 2.3952 mL | 4.7904 mL | 9.5808 mL | 11.976 mL |
10 mM | 0.2395 mL | 1.1976 mL | 2.3952 mL | 4.7904 mL | 5.988 mL |
50 mM | 0.0479 mL | 0.2395 mL | 0.479 mL | 0.9581 mL | 1.1976 mL |
100 mM | 0.024 mL | 0.1198 mL | 0.2395 mL | 0.479 mL | 0.5988 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Taiwanin E
Catalog No.:BCN9612
CAS No.:22743-05-1
- 5-Methoxyjusticidin A
Catalog No.:BCN9611
CAS No.:205505-62-0
- 3-O-(p-Hydroxybenzoyl)serratriol
Catalog No.:BCN9610
CAS No.:1448534-93-7
- Karavilagenin F
Catalog No.:BCN9609
CAS No.:1639024-15-9
- Apigenin 7-O-(2'',6''-di-O-E-p-coumaroyl)glucoside
Catalog No.:BCN9608
CAS No.:1448779-19-8
- Beiwutine
Catalog No.:BCN9607
CAS No.:76918-93-9
- Taiwanin C
Catalog No.:BCN9606
CAS No.:14944-34-4
- Stepharine
Catalog No.:BCN9605
CAS No.:2810-21-1
- 7,7'-Dihydrotaiwanin C
Catalog No.:BCN9604
CAS No.:216955-79-2
- Menisdaurilide
Catalog No.:BCN9603
CAS No.:67765-59-7
- Aquilegiolide
Catalog No.:BCN9602
CAS No.:94481-79-5
- 16-Oxoserratenediol
Catalog No.:BCN9601
CAS No.:24513-52-8
- Illiciumlignan D
Catalog No.:BCN9614
CAS No.:2237239-36-8
- Tuberculatin
Catalog No.:BCN9615
CAS No.:90706-10-8
- Greveichromenol
Catalog No.:BCN9616
CAS No.:35930-29-1
- Cernuine
Catalog No.:BCN9617
CAS No.:6880-84-8
- Karavilagenin B
Catalog No.:BCN9618
CAS No.:912329-02-3
- Heteropeucenin 7-methyl ether
Catalog No.:BCN9619
CAS No.:26213-95-6
- Alloptaeroxylin
Catalog No.:BCN9620
CAS No.:4670-29-5
- 7α-O-Ethylmorroniside
Catalog No.:BCN9621
CAS No.:1116650-29-3
- O-Methylalloptaeroxylin
Catalog No.:BCN9622
CAS No.:35930-31-5
- 16-Oxo-21-episerratenediol
Catalog No.:BCN9623
CAS No.:1194739-51-9
- Umtatin
Catalog No.:BCN9624
CAS No.:17398-06-0
- Dihydrodehydrodiconiferyl Alcohol Beta-D-Xylopyranoside
Catalog No.:BCN9625
CAS No.:1048996-18-4
FK-3000 isolated from Stephania delavayi Diels. inhibits MDA-MB-231 cell proliferation by decreasing NF-kappaB phosphorylation and COX-2 expression.[Pubmed:25823424]
Int J Oncol. 2015;46(6):2309-16.
The World Health Organization (WHO) has reported that cancer is one of the most prevalent diseases and a leading cause of death worldwide. Many anticancer drug development studies have been pursued over the last few decades and several viable drugs have been discovered, such as paclitaxel, topotecan and irinotecan. Previously, our research group uncovered the cytocidal and cytostatic effects of the plant Stephania delavayi Diels. In this study, we determined the active chemical to be 6,7-Di-O-acetylsinococuline (FK-3000). The FK-3000 half maximal inhibitory concentration (IC50) in MDA-MB-231 breast carcinoma cells at 48 h was 0.52 microg/ml and it induced apoptosis in a dose- and time-dependent manner. FK-3000 suppressed NF-kappaB nuclear translocation, decreased NF-kappaB phosphorylation, and decreased COX-2 protein expression. MDA-MB-231 xenografted mice were treated with FK-3000, Taxol, or their combination for 21 days. The tumor size was smallest in the co-treatment group, indicating that FK-3000 may have a synergistic effect with Taxol. FK-3000 treatment showed no adverse effects on blood cell counts, serum protein levels, or pathology. These studies demonstrate that FK-3000, isolated from S. delavayi Diels., is a promising, pathway-specific anticancer agent that exhibits low toxicity.
6,7-di-O-acetylsinococuline (FK-3000) induces G2/M phase arrest in breast carcinomas through p38 MAPK phosphorylation and CDC25B dephosphorylation.[Pubmed:25384584]
Int J Oncol. 2015 Feb;46(2):578-86.
We evaluated the cytostatic effect of 6,7-di-O-acetyl-sinococuline (FK-3000) isolated from Stephania delavayi Diels. against breast carcinoma cell lines MDA-MB231 and MCF-7. FK-3000 suppressed CDC25B phosphorylation directly and indirectly via p38 MAPK phosphorylation. CDC25B dephosphorylation decreased levels of cyclin B and phospho-CDC-2, and ultimately induced cell cycle arrest at the G2/M phase. The p38 MAPK inhibitor, SB 239063 blocked FK-3000-induced p38 MAPK phosphorylation and nuclear accumulation, but did not completely rescue cell death. Conclusively FK-3000 exerts its antiproliferative effect through two pathways: i) G2/M cell cycle arrest via downregulation of cyclin B and phospho-CDC2 by p38 MAPK phosphorylation and CDC25B dephosphorylation, and ii) p38 MAPK-independent induction of apoptosis.
Dynamic pH junction high-speed counter-current chromatography coupled with microwave-assisted extraction for online separation and purification of alkaloids from Stephania cepharantha.[Pubmed:23891210]
J Chromatogr A. 2013 Nov 22;1317:203-10.
A simple and efficient dynamic pH junction high-speed counter-current chromatography method was developed and further applied to the online extraction, separation and purification of alkaloids from Stephania cepharantha by coupling with microwave-assisted extraction. Mineral acid and organic base were added into the mobile phase and the sample solution, respectively, leading to the formation of a dynamic pH junction in the column and causing focus of alkaloids. Selective focus of analytes can be achieved on the basis of velocity changes of the pH junction through appropriate selection of solvent systems and optimization of additive concentrations. The extract can be directly introduced into the HSCCC for the online extraction, separation and purification of alkaloids from S. cepharantha. Continuous separation can be easily achieved with the same solvent system. Under the optimum conditions, 6.0 g original sample was extracted with 60 mL of the upper phase of hexane-ethyl acetate-methanol-water (1:1:1:1, v/v/v/v) containing 10% triethylamine under 50 degrees C and 400 W irradiation power for 10 min, the extracts were directly separated and purified by high-speed counter-current chromatography. A total of 5.7 mg sinomenine, 8.3mg 6,7-Di-O-acetylsinococuline, 17.9 mg berbamine, 12.7 mg isotetrandrine and 14.6 mg cepharanthine were obtained with purities of 96.7%, 93.7%, 98.7%, 97.3% and 99.3%, respectively. The online method provides good selectivity to ionizable compounds and improves the separation and purification efficiency of the high-speed counter-current chromatography technique. It has good potential for separation and purification of effective compounds from natural products.